Atrial Fibrillation Ablation Should Be First-line Therapy in Patients with Heart Failure Reduced Ejection Fraction

Pradyumna Agasthi, Andrew Tseng, Justin Z. Lee, Siva Mulpuru

Research output: Contribution to journalReview article

Abstract

Catheter ablation for atrial fibrillation in patients with heart failure with reduced ejection fraction is associated with improvement in patient-centered outcomes, such as mortality, heart failure readmission, and atrial fibrillation recurrence, compared with standard medical therapy with or without device therapy. The evidence is not as robust in patients with atrial fibrillation and heart failure with preserved ejection fraction.

Original languageEnglish (US)
JournalCardiology clinics
DOIs
StatePublished - Jan 1 2019

Fingerprint

Atrial Fibrillation
Heart Failure
Catheter Ablation
Therapeutics
Recurrence
Equipment and Supplies
Mortality

Keywords

  • Atrial fibrillation
  • Catheter ablation
  • Heart failure hospitalization
  • Mortality
  • Pharmacologic therapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Atrial Fibrillation Ablation Should Be First-line Therapy in Patients with Heart Failure Reduced Ejection Fraction. / Agasthi, Pradyumna; Tseng, Andrew; Lee, Justin Z.; Mulpuru, Siva.

In: Cardiology clinics, 01.01.2019.

Research output: Contribution to journalReview article

@article{b1053021e99f4870b0360b656ce36f9b,
title = "Atrial Fibrillation Ablation Should Be First-line Therapy in Patients with Heart Failure Reduced Ejection Fraction",
abstract = "Catheter ablation for atrial fibrillation in patients with heart failure with reduced ejection fraction is associated with improvement in patient-centered outcomes, such as mortality, heart failure readmission, and atrial fibrillation recurrence, compared with standard medical therapy with or without device therapy. The evidence is not as robust in patients with atrial fibrillation and heart failure with preserved ejection fraction.",
keywords = "Atrial fibrillation, Catheter ablation, Heart failure hospitalization, Mortality, Pharmacologic therapy",
author = "Pradyumna Agasthi and Andrew Tseng and Lee, {Justin Z.} and Siva Mulpuru",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.ccl.2019.01.004",
language = "English (US)",
journal = "Cardiology Clinics",
issn = "0733-8651",
publisher = "W.B. Saunders Ltd",

}

TY - JOUR

T1 - Atrial Fibrillation Ablation Should Be First-line Therapy in Patients with Heart Failure Reduced Ejection Fraction

AU - Agasthi, Pradyumna

AU - Tseng, Andrew

AU - Lee, Justin Z.

AU - Mulpuru, Siva

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Catheter ablation for atrial fibrillation in patients with heart failure with reduced ejection fraction is associated with improvement in patient-centered outcomes, such as mortality, heart failure readmission, and atrial fibrillation recurrence, compared with standard medical therapy with or without device therapy. The evidence is not as robust in patients with atrial fibrillation and heart failure with preserved ejection fraction.

AB - Catheter ablation for atrial fibrillation in patients with heart failure with reduced ejection fraction is associated with improvement in patient-centered outcomes, such as mortality, heart failure readmission, and atrial fibrillation recurrence, compared with standard medical therapy with or without device therapy. The evidence is not as robust in patients with atrial fibrillation and heart failure with preserved ejection fraction.

KW - Atrial fibrillation

KW - Catheter ablation

KW - Heart failure hospitalization

KW - Mortality

KW - Pharmacologic therapy

UR - http://www.scopus.com/inward/record.url?scp=85061551905&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061551905&partnerID=8YFLogxK

U2 - 10.1016/j.ccl.2019.01.004

DO - 10.1016/j.ccl.2019.01.004

M3 - Review article

JO - Cardiology Clinics

JF - Cardiology Clinics

SN - 0733-8651

ER -